HomeVERA • NASDAQ
add
Vera Therapeutics Inc
Previous close
$39.07
Day range
$38.00 - $39.60
Year range
$18.53 - $56.05
Market cap
2.78B USD
Avg Volume
1.02M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 94.21M | 92.60% |
Net income | -91.10M | -109.78% |
Net profit margin | — | — |
Earnings per share | -1.39 | -93.06% |
EBITDA | -94.07M | -92.54% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 714.59M | 11.51% |
Total assets | 734.73M | 12.06% |
Total liabilities | 130.21M | 65.82% |
Total equity | 604.52M | — |
Shares outstanding | 71.36M | — |
Price to book | 4.61 | — |
Return on assets | -37.61% | — |
Return on capital | -40.68% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -91.10M | -109.78% |
Cash from operations | -69.99M | -78.64% |
Cash from investing | 80.66M | 136.44% |
Cash from financing | 286.28M | -12.17% |
Net change in cash | 296.95M | 354.12% |
Free cash flow | -37.94M | -43.94% |
About
Founded
2016
Headquarters
Website
Employees
249
